Trial
NCT04510428
OSIG-eye Drops Treatment for Dry Eye Disease
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Illinois at Chicago
Collaborators
—
Condition
Dry Eye
Intervention
Ocular Surface Immune Globulin (OSIG)
Why stopped
Study not initiated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-23